Dopamine receptor interacting proteins (DRIPs) of dopamine D1-like receptors in the central nervous system

被引:0
|
作者
Wang, Min [1 ]
Lee, Frank J. S. [1 ]
Liu, Fang [1 ,2 ]
机构
[1] Ctr Addict & Mental Hlth, Dept Neurosci, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada
关键词
dopamine; dopamine D1-like receptors; dopamine receptor-interacting proteins (DRIPs); neuropsychiatric; disease;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dopamine is a major neurotransmitter in the mammalian central nervous system (CNS) that regulates neuroendocrine functions, locomotor activity, cognition and emotion. The dopamine system has been extensively studied because dysfunction of this system is linked to various pathological conditions including Parkinson's disease, schizophrenia, Tourette's syndrome, and drug addiction. Accordingly, intense efforts to delineate the full complement of signaling pathways mediated by individual receptor subtypes have been pursued. Dopamine D1-like receptors are of particular interest because they are the most abundant dopamine receptors in CNS. Recent work suggests that dopamine signaling could be regulated via dopamine receptor interacting proteins (DRIPs). Unraveling these DRIPs involved in the dopamine system may provide a better understanding of the mechanisms underlying CNS disorders related to dopamine system dysfunction and may help identify novel therapeutic targets.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 50 条
  • [41] Suppression of excitatory cholinergic synaptic transmission by Drosophila dopamine D1-like receptors
    Yuan, Ning
    Lee, Daewoo
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2007, 26 (09) : 2417 - 2427
  • [42] Juvenile hormone synthesis is stimulated by activation of dopamine D1-like receptors in Drosophila
    I. Y. Rauschenbach
    E. K. Karpova
    E. V. Bogomolova
    O. V. Laukhina
    N. E. Gruntenko
    Doklady Biochemistry and Biophysics, 2011, 441 : 273 - 275
  • [43] Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors
    Yasunari, K
    Kohno, M
    Hasuma, T
    Horio, T
    Kano, H
    Yokokawa, K
    Minami, M
    Yoshikawa, J
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 3164 - 3173
  • [44] Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D1-Like receptors
    Yasunari, K
    Kohno, M
    Kano, H
    Minami, M
    Yoshikawa, J
    CIRCULATION, 2000, 101 (19) : 2302 - 2308
  • [45] Transient expression of an atypical D1-like dopamine receptor system during avian retina differentiation
    deMello, MCF
    Pinheiro, MCC
    deMello, FG
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1996, 29 (08) : 1035 - 1044
  • [46] Dopamine suppresses persistent network activity via D1-like dopamine receptors in rat medial entorhinal cortex
    Mayne, Elizabeth W.
    Craig, Michael T.
    McBain, Chris J.
    Paulsen, Ole
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2013, 37 (08) : 1242 - 1247
  • [47] Methamphetamine exacerbates neuroinflammatory response to lipopolysaccharide by activating dopamine D1-like receptors
    Wang, Biao
    Chen, Teng
    Xue, Li
    Wang, Jing
    Jia, Yuwei
    Li, Guodong
    Ren, Huixun
    Wu, Feng
    Wu, Min
    Chen, Yanjiong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 73 : 1 - 9
  • [48] Facilitatory effect of dopamine on neuromuscular transmission mediated via dopamine D1-like receptors and prospective interaction with nicotine
    AlQot, H. E.
    Elnozahi, N. A.
    El-Din, M. M. Mohy
    Bistawroos, A. E.
    Abou Zeit-Har, M. S.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 765 : 51 - 57
  • [49] Role for D1-like and D2-like dopamine receptors in the modulation of intestinal motility in mice
    Zizzo, M. G.
    Auteri, M.
    Mastropaolo, M.
    Serio, R.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 : 109 - 109
  • [50] DOPAMINE-RECEPTORS IN THE CENTRAL NERVOUS-SYSTEM
    CREESE, I
    SIBLEY, DR
    HAMBLIN, MW
    LEFF, SE
    ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY, 1983, 36 : 125 - 134